A big thank you to 471 respondents who took the time to complete CCSN’s questionnaire and helped make it a success!
Studies on gaps in cancer rehabilitation services for survivors show that it is a nationwide problem, which is why Jackie Manthorne, CCSN‘s President & CEO and Alex Wyatt, CCSN’s Public Policy Coordinator, travelled across the country to Alberta to host CCSN’s second All-party Cancer Caucus meeting in Edmonton on October 29 on the topic of lymphedema. Lymphedema is a chronic and progressive inflammatory disease commonly caused by cancer treatments that damage the lymphatic system.
By Marina Canalejo, Public Policy Assistant, Canadian Cancer Survivor NetworkEdited by Jacqueline Thurston, Communications and Social Media Assistant A new series of worldwide outbreaks has seen the return of a serious and deadly infectious disease: measles. Measles is a highly contagious disease that is transmitted through the air or through direct contact with someone who is infected. Complications such as pneumonia, dehydration, and acute encephalitis
The Canadian Cancer Survivor Network currently has two feedback opportunities for prostate cancer patients and caregivers. Please read below for more information. If you qualify to take these surveys, we would appreciate you taking a few minutes to do so. If you have any questions, please contact Allison at firstname.lastname@example.org. Prostate Cancer Patient/Survivor/Caregiver Questionnaire All patients, survivors and caregivers who have faced or are facing
By Marina Canalejo CCSN Web Policy Assistant When you hear the word immunotherapy what comes to mind? An obscure therapy of some sort that has not yet been very well explained? In this article, you will find out about the immune system, how it works and how these new immunotherapies are helping our own bodies attack and kill cancer wherever it might be. The immune
By Marina Canalejo CCSN Web Policy Assistant In February of this year, a commission led by former Ontario Health Minister Eric Hoskins was formed to study the cost of prescription drugs and the possibility of creating a national pharmacare strategy. Proponents of this system argue that the federal government has a larger role to play than just helping the provinces reduce costs by ensuring adequate